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INTRODUCTION 
 
 Rafi et al
(8)
 first in 2001 described a relatively new 
technique named Transverse Abdominis Plane block.   It is 
a type of regional anaesthesia that provides analgesia to 
pain arising from the pareital peritoneum, skin and muscles 
of anterior abdominal wall. This technique is technically 
safe to perform especially under ultrasound guidance.  
 
 These studies showed that Transverse Abdominis 
Plane Block significantly reduced the requirement of 
analgesics, but the effect wore off within 24 hours. So the 
trend now is performing studies directed towards 
continuous Transverse Abdominis Plane block and thus, 
obtain its benefit for a prolonged period.  
 
 Effective pain control is a very important aspect in 
patients undergoing surgeries, especially in parturient 
mothers undergoing caesarean section. They have to be 
alert, awake and painless so as to take good care of 
newborn baby.  
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 We have been using epidural analgesia for 
postoperative pain relief using local anaesthetic agents with 
or without supplemental opioids. However there is always a 
major group of patients in whom this technique is not used. 
Also there is a small group of patients in whom this 
contraindicated or not possible.  
 
 These patients receive intravenous opioids through 
Patient Controlled Analgesia system for postoperative 
analgesia. Apart from being less efficient in providing 
analgesia, the opioid related side effects like nausea, 
vomiting, respiratory depression, sedation are of major 
concerns. In addition these opioids can get transferred 
through lactation and affect the newborn. Thus addition of 
Transverse Abdominis Plane block certainly will reduce the 
requirement of opioids by blocking the somatic component 
of pain.  
 
 Performing this block under ultrasound guidance 
increases the safety of this block. And continuing this 
analgesia by placement of a catheter in situ will 
3 
 
significantly reduce the total opioid consumption 
postoperatively.  
 
 Keeping this in mind we conducted a double blinded 
prospective randomised control study at Institute of 
Obstetrics and Gynaecology, where patients undergoing 
caesarean section under spinal anaesthesia were given 
bilateral continuous Transverse Abdominis Plane  blocks 
after surgery and intravenous Fentanyl given on demand.  
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AIM OF THE STUDY 
                      
 To evaluate the efficacy of ultrasound guided 
Transverse Abdominis Plane block as continuous analgesic 
technique, thus ultimately reducing post operative opioid 
requirements.  
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ULTRASONOGRAM – PRICIPLES
(22)  
 
 
Ultrasonogram is based upon the principle of piezoelectric 
effect. 
• This phenomenon was discovered by the Curies in 
1880 using natural quartz 
• Applied in use for Diagnostic Medical applications 
since late 1950‟s  
• Frequency ranges used in medical ultrasound imaging 
range from 2 - 15 MHz 
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PIEZOELECTRIC EFFECT 
 Piezoelectric Effect is defined as the principle of 
converting electrical energy into mechanical energy. The 
reverse of the piezoelectric effect converts the energy back 
to its original form.  
 
PIEZOELECTRIC EFFECT AND ULTRASOUND 
TRANSDUCERS 
• A transducer converts one type of energy into  another. 
• Based upon the pulse-echo principle , transducers 
convert: 
a. Electricity into sound = pulse 
b. Sound into electricity = echo 
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PULSE 
• Pulse is the wave which is sent to the soft tissues  
• Interaction of this sound wave with soft tissue is 
called bio effect. 
• Pulsing is determined by the transducer or probe 
crystal(s) and is not operator controlled . 
 
ECHO 
• Echo is wave produced by soft tissues  
• Echoes are received back by the transducer crystals 
which are interpreted and processed  by the ultrasound 
machine. 
 
FREQUENCY 
• Number of complete cycles per unit of time  
• One cycle per second = one Hertz (Hz) 
• Transducer Frequencies:  
• 2.5 – 3.5 MHz – abdomen, obstetrics and gynaecology 
• 5.0 – 7.5 MHz – breast, thyroid 
• 7.5 – 10 MHz – Superficial veins, Superficial structures 
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Thus 
 High frequency gives 
– Improved resolution with less depth of penetration 
– Used for superficial uses 
 Low frequency gives  
– Poorer resolution with full depth of penetration 
– For general abdomino-pelvic uses 
 Transducer frequency in ultrasound machine is 
predetermined by design 
 
 
WAVELENGTH 
• Distance between consecutive cycles of sound.  
 
BANDWIDTH 
• A range of frequencies is termed bandwidth 
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• Broad bandwidth transducers contain more than one 
operating frequency 
 
AXIAL & LATERAL RESOLUTION 
• Spatial Resolution describes how physically close two 
objects can be and displayed separately.  
– Axial: along the beam path 
– Lateral: perpendicular to beam path  
• Normally used spatial resolution is1.0 mm or less.  
 
MACHINE COMPONENTS 
1. TRANSDUCER 
 
 
Types: 
• Mechanical 
– Oscillating 
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– Rotating 
• Electronic 
– Linear Arrays 
– Curved Arrays 
– Phased Arrays 
2. RECEIVER 
3. MEMORY 
4. DISPLAY 
 
FIELD OF VIEW SHAPES 
Sector FOV  
 
• Produced by oscillating/ rotating curved arrays, 
phased arrays 
• Typically used in cardiac and abdominal application 
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Linear FOV  
 
• Produced by linear arrays 
• Typically used in superficial application 
 
PROBE TYPES 
 
CURVI Linear, Low Frequency Probe 
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Linear, High Frequency Probe 
 
DISPLAY MODES 
• B Mode  - 2 dimensional 
• M Mode - records moving echoes from the heart in 
display, thus the motion could be interpreted in terms 
of myocardial and valvular function.  
• Doppler - here the frequency shift in echo is 
measured after a certain time.  
• Colour Doppler  - uses colour corresponding to 
frequency shift; red for near to and blue for away 
from the probe. 
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ANATOMY OF ANTERIOR ABDOMINAL 
WALL
(24,25)  
 
 The anterior abdominal wall is innervated by the 
anterior primary rami of – L1 spinal nerves. The anterior 
primary rami travel anteriorly and supply the anterior 
abdominal wall.  
 
Nerve supply of anterior abdominal wall  
 
 The anterior rami of T7 – T11 travel anteriorly in the 
intercostal space giving rise to a lateral cutaneous branch 
after piercing through external abdominis muscle.  
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 This further divides into an anterior and posterior branch 
thatsupply the external oblique and lattismus dorsi 
respectively. 
 They continue anteriorly in between internal oblique and 
transverse abdominis muscles until they reach rectus 
abdominis, wherein they give rise to anterior cutaneous 
branch and ends by supplying the skin of anterior 
abdominal wall.  
 
 
ANATOMY OF NERVE SUPPLY 
 The anterior rami of T12 descends in between internal 
oblique and transverse abdominis muscles, giving rise 
to a lateral cutaneous branch which pierces the 
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external oblique to supply skin over front part  of 
gluteal region. 
  It communicates with the iliohypogastric nerve and 
gives motor supply to the pyramidalis and the rectus 
muscles.  
 The rami of L1 lies in between internal oblique and 
transverse abdominis muscle, near the iliac crest, 
supplying a part of skin covering genitalia, upper and 
medial part of the thigh.   
LOWER LUMBAR TRIANGLE OF PETIT
(23 ,  24 ,5 ,13)  
 This is a deficiency in the anterior abdominal muscle 
wall, situated in between iliac crest and lower costal 
margin in the midaxillary line.  
 Bounded anteriorly by lateral border of external 
oblique and posteriorly by the lateral border of 
lattismus dorsi.  
 Base is formed by the aponeurosis of external, 
internal oblique and transverse abdominis muscle. 
Thus it gives the characteristic „pop of‟ feel we get 
during blind method of Transverse Abdominis Plane 
block.  
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 Sometimes it will be difficult to identify this triangle 
in obese patients wherein it is suggested to insert the 
needle about 2.5 cm behind the highest point of iliac 
crest.  
 Lifting up of the head and shoulder with patient in 
supine position causes contraction of the abdominal 
muscles and facilitate in palpation of this triangle. 
Thus this is a very important landmark for Transverse 
Abdominis Plane block.  
 
BLOCK TECHNIQUE 
 The aim of this technique is to deposit the local 
anaesthetic solution in between internal oblique and 
transverse abdominis muscle so that the spinal nerves 
passing in this plane get blocked. This block requires high 
volume of local anaesthetic, so the dose is calculated and 
administered in lower concentrations safely so as to not 
exceed toxic limits.  
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There are 3 techniques through which we can enter this 
tissue plane: 
1. Anatomical landmark based 
2. Ultrasound guided 
3. Surgeon assisted approach 
 
Blind method: 
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 In the anatomical landmark based technique, we enter 
the plane through the Petit‟s triangle, wherein we rely 
upon two characteristic „pop of‟ sensation while 
passing a blunt needle through it.  
 The first pop of occurs when we pierce through the 
external oblique aponeurosis and second one by 
internal oblique aponeurosis.  
 Optimal positioning is supine position without any 
hip flexion. To accentuate the border of latismus 
dorsi, ipsilateral arm can be raised above head level.  
  In obese patients however excessive subcutaneous fat 
increases the depth of Transverse Abdominis Plane. 
Thus in supine position the excessive fat hangs over 
the flanks, making it difficult for needle placement 
and visualisation and also ultrasound probe 
positioning. In such cases semilateral position is 
ideal, by placing a wedge on the ipsilateral side.  
 Petit‟s triangle is identified by palpating the anterior 
iliac crest and following posteriorly until reaching 
latismus dorsi. Skin may be marked using a marker to 
make it easier.  
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STEPS OF TAP BLOCK
(8 ,5 ,24 ,  25)  
 As this is an invasive procedure into a relatively 
avascular plane, sterile aseptic precautions are to be 
followed. Skin is disinfected using povidone iodine with 
a minimum contact time of 3 minutes.  
  If patient is not having adequate level of blockade or 
not sedated, local infiltration of the entry point with 1 – 
3ml of 2% lignocaine, using an intramuscular needle. 
Patients having residual spinal or epidural effect will 
not require this. 
 A 22G, 2 inches long needle with a blun ted end provides 
a good sensation of the different muscle layers passed 
through. 
 With the anaesthetist standing on opposite or same side, 
the needle is placed in 90º angle and inserted in the 
middle of the triangle of Petit.  
  Two significant pops corresponding to the external and 
internal oblique aponeurosis will be felt.  
  After the second pop, which is approximately 1 – 1.5 
inches deep, we will be lying in the plane between 
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internal oblique and transverse abdominis muscle, 
wherein the neural bundle is avai lable. 
  Local anaesthetic solution is injected following 
negative aspiration, in increments. Usually second pop 
of is felt within 1cm apart the first one. If failure to 
detect this pop feel, needle must be withdrawn and 
procedure repeated. 
 For incisions confined to one side of the midline, 
unilateral blocks are enough, Eg. Inguinal hernia, 
appendicectomy; whereas incisions crossing the midline 
Eg. Pfannensteil, bilateral blocks will be required.  
  This Transverse Abdominis Plane block takes upto 
30min to be effective and hence supplementation with an 
opioid will be required during start of surgery.  
Ultrasound guided method:  
 Here we use a high frequency probe (7 – 12 Hz) 
placed in middle between lower costal margin and iliac 
crest in the midaxillary line. The probe is first kept 
anteriorly over rectus sheath and then drawn laterally to 
follow the fascial planes correctly.  
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An ideal view demonstrates  
 Subcutaneous tissue 
 External oblique muscle 
 Internal oblique muscle 
 Transverse abdominis muscle 
 Peritoneum 
 Intraabdominal organs. 
 
STEPS OF TAP BLOCK 
 A 20G, 10 cm long needle is preferable. After 
visualising the plane with the ultrasound probe, the 
needle is introduced anteriorly in-plane or out of 
plane, visualising the whole needle length and/or tip 
of the needle respectively.  
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  After placement in plane, confirm by injecting 1 – 
2ml of the anaesthetic solution – Hydrodissection 
method – which makes visualisation of the plane 
easier and also makes catheter placement for 
continuous Transverse Abdominis Plane block easier.  
 Correct placement produces an echoluscent, lens 
shaped space with clear borders lying within the 
internal oblique and transverse abdominis plane.  
 
3. Surgeon assisted approach:  
 It is used along with blind method. Here the injection 
site is observed through a laparoscopic camera, a peritoneal 
bulge will be seen if block is correctly delivered. Also a 
method of direct visualisation of Transverse Abdominis 
Plane block by dissecting through the internal and external 
oblique muscles have been described in a study done by 
Araco et al.  
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PHARMACOLOGY OF BUPIVACAINE
(1,3,4,5)  
  
 Bupivacaine is an amide local anaesthetic, synthesized 
by A.F.Ekenstam in 1957 and brought into clinical use in 
1963. 
 It is produced for clinical use in a racemic mixture, 
containing equal proportions of the „S‟ and „R‟ 
enantiomers. It is supplied for clinical use as a 
hydrochloride salt.  
 
Chemical Structure 
 Description: ± 1- Butyl-N-(2, 6-dimethylphenyl) – 2- 
piperidine Decarboxamide Hydrochloride monohydrate.  
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Physico-chemical Profile  
Molecular weight (base)  - 288 
pKa      - 8.1 
Lipid Solubility    - 28 
Plasma Protein Binding  - 95% 
 
Mechanism of Action 
 Bupivacaine exerts its effects by inhibition of sodium 
channels. It acts by blocking the conduction in the 
nerves. 
 This occurs by decrease in or prevention of the large 
transient increases in permeability of the cell 
membrane to sodium ions that follows depolarization 
of the membrane.  
 Bupivacaine also reduces the permeability of the 
resting nerve membrane to potassium as well as 
sodium ions. 
 
Pharmacodynamics 
 Bupivacaine by virtue its pharmacological effects, has 
a stabilizing action on all excitable membranes. In the 
central nervous system, stimulation can occur producing 
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restlessness, tremors and convulsions in over  dosage. 
Bupivacaine also causes a reduction in the automaticity of 
the heart. 
 
 The clinical profile of nerve blockade produced by 
Bupivacaine differs from that of lignocaine. It is 4 times 
more potent than lignocaine, but the onset of action is 
slower. The duration of action is considerably longer. The 
sensory block produced by Bupivacaine tends to be more 
marked than the motor block. 
 
Pharmacokinetics 
 Bupivacaine is rapidly absorbed from the site of 
injection. The rate of rise in plasma Bupivacaine 
concentration and the peak plasma concentrations obtained 
depend on the route of administration.  
 
 There is also some inter individual variation and peak 
systemic concentrations may occur between 5 and 30 
minute after administration. The addition of vasoconst rictor 
delays absorption and results in lower plasma concentration 
of Bupivacaine. 
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Pharmacokinetic Profile 
Volume of distribution at steady rate (Vdss)  72 lrs 
Clearance        0.47 L.min 
t½α         2.7 min 
t½β         28 min 
t½γ         3.5 hrs 
 
Metabolism 
 Possible pathways for metabolism of Bupivacaine 
include aromatic hydroxylation, N-dealkylation, amide 
hydrolysis and conjugation. Only the N-dealkylated 
metabolic N-esmethylbupivacaine has been measured in 
blood and urine after epidural and spinal admin istration. 
 
 The degradation of Bupivacaine takes place in the 
liver. Renal disease is unlikely to alter the kinetics of 
Bupivacaine to any great extent. Less than 10% of the drug 
is excreted unchanged in urine.  
 
 The onset of action of Bupivacaine occurs 20-30 
minutes after a peripheral nerve block and duration lasts for 
8-9 hours. 
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Clinical Applications 
 Infiltration anaesthesia 
 Peripheral nerve blocks 
 Central neruraxial blocks (intrathecal, epidural and 
caudal) 
 
Contradictions 
 Para cervical block  
 Known hypersensitivity to amide local anaesthetics  
 Intravenous regional anaesthesia (IVRA)  
 
Preparations available 
• 0.25%, 0.5% solutions in 10 ml and 20 ml vials.  
• 5mg/ml (0.5%) bupivacaine and 80 mg dextrose in 4 
ml ampoules for intrathecal injection (Baricity 
1.0207) 
 
Recommended Safe Dose 
Concentration Used Maximum Permitted  Dose 
0.125%-0.5% 3mg/kg body weight 
0.75% (not to be used in Max.over 4 hrs-150mg 
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obstetric epidurals) Max. During 24 hrs-400 mg 
0.5% plain/hyperbaric 
solution (intrathecal use)  
20 mg 
 
Adverse Reactions 
 Adverse reactions are associated mainly with excess 
plasma levels of the drug, which may due to over dosage, 
unintentional intravascular injection or slow metabolic 
degradation. 
 
CNS Reactions 
 Excitation characterized by restlessness,  anxiety, 
dizziness, tinnitus blurred vision or tremors possibly 
proceeding to convulsions, followed by drowsiness, 
unconsciousness and cardiac arrest.  
 
Cardiovascular System Effects  
 Part of the cardiac toxicity that occurs from high 
plasma concentrations of Bupivacaine occurs because of 
blockade of cardiac sodium channels. Accidental 
intravenous injection of Bupivacaine causes cardiac 
dysarrthymias, atrioventricular block, verticular tachycardia 
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and ventricular fibrillation. Pregnancy increases the 
sensitivity of cardio toxic effects of Bupivacaine.  
 
Allergic Reactions 
 Manifests as urticaria, pruritus, angioneurotic edema 
etc. Cross sensitivity among members of amide type local 
anaesthetics has been reported.  
 
          With prolonged infusions there is the potential for 
delayed systemic accumulation and toxicity. Continuous 
bupivacaine  infusions of up to 30 mg/hr in adults for as 
long as 2 weeks produced no overt CNS or cardiac toxicity 
despite total plasma bupivacaine concentrations in the range 
of 2 to 5 µg/mL in several patients.  
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PHARMACOLOGY OF FENTANYL
(1,3,4 ,5)  
  
 Fentanyl is a synthetic opioid which is a 
phenylpiperidine derivative which acts as µ agonists. First  
synthesised by Paul Janssen in 1960.  
 
Physico chemical properties  
 Has a pKa of 8.4 
  84% bound to plasma proteins.  
 Volume of distribution in steady state is 3 – 5 L/kg. 
 
Opioid receptors 
 There are 3 receptors - µ, κ, δ. All of these are 
involved involved in supraspinal and spinal analgesia.  
 
µ receptor   
 Located predominantly in brain and spinal cord 
 3 subtypes - µ1 , µ2 , µ3 .  
 Especially related to decreasing respiratory function, 
increasing sedation.  
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Mechanism of action: 
Belong to G protein coupled receptors  
↓ 
Activation of opioid receptor  
↓ 
Inhibition of Adenylyl cyclase  
↓ 
Reduced ćAMP  
↓ 
Inhibition of voltage gated Ca
++
 channel and 
Activation of K
+ 
channel 
↓ 
Reduced neuronal excitability 
 
Pharmacokinetics 
 pKa of 8.4, 10% unionised at physiological pH 
 It has a half life of  t 1/2α  – 1–2min, t1/2β – 10–30min, t1 /2γ  
– 2–4hrs  
 84% bound to plasma proteins 
 Volume of distribution at steady state – 3-5 L/kg 
 Lungs exert first pass effect by taking up 75% of 
fentanyl 
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 RBCs also take up about 40% of the drug.  
 Highly lipid soluble.  
 Metabolised in liver by N-dealkylation and 
hydroxylation, producing the metabolite Norfentanyl.  
 
Effects on central nervous system 
 Dose related reduction in Cerebral blood flow and 
Cerebral metabolic oxygen requirements occurs.  
 
Effects on respiratory system 
 Reduction of ventilatory drive and response to pCO 2  
changes 
 Depresses airway reflexes blunts somatic and autonomic 
response to intubation 
 Has antimuscarinic, antihistaminergic and 
antiseratoninergic actions, so more effective than 
morphine in patients with bronchospasm 
 Respiratory depression caused by morphine is long lasing 
than equipotent doses of fentanyl.  
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Effect on cardiovascular system 
 Provides hemodynamic stability throughout 
intraoperative period 
 Stimulates central vagal nucleus and produces 
bradycardia. Also blockade of symphathetic response to 
pain is reduced due to its analgesic action.  
 Fentanyl produces little or no change in myocardial 
contractility, but morphine reduces isometric contraction 
force of heart.  
 Depresses baroreceptor reflex.  
 Antiarrhythmogenic 
Unlike morphine, fentanyl doesnot cause histamine 
release 
 
Endocrine 
 Reduces release of stress response harmones – cortisol, 
catecholamines – and Antidiuretic harmone.  
 Fentanyl is more effective than morphine in modifying 
harmone responses to surgery 
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Renal system 
 Retention of urine 
 
Gastrointestinal system 
 Reduces motility 
 Stimulates Chemoreceptor Trigger Zone and produces 
nausea and vomiting 
 
Obstetrics and lactation  
 Fentanyl belongs to Category C group of drugs. 
However its use is  allowed by American Society of  
Paediatrics. Although fentanyl is concentrated in breast 
milk, no adverse fentanyl-related effects were observed in a 
breastfed infant whose mother used fentanyl transdermal 
patches (100mcg/hour) during lactation. Though fentanyl 
concentrations in the mother‟s milk were 6.4ng/ml, blood 
samples from the baby were negative for fentanyl or its 
metabolites. Because of these reasons we preferred to use 
fentanyl instead of morphine in our study.  
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REVIEW OF LITERATURE 
 
1. Rao V Kadam et al, 2011
(5)  
 Conducted a study in which 20 patients were randomly 
allocated into two groups – Transverse Abdominis Plane 
group and control group. The study was conducted to 
evaluate the efficacy of ultrasound guided Transverse 
Abdominis Plane block, comparing with patient controlled 
analgesia with fentanyl in patients undergoing major 
abdominal surgeries.  
 
 Both groups were done under General anaesthesia and 
Transverse Abdominis Plane block was given at the end of 
the surgery under ultrasound guidance and an epidural 
catheter placed within the plane. 
  
 Transverse Abdominis Plane group received 15ml of 
0.5% ropivacaine initial bolus bilaterally followed by 
continuous infusion of 8 – 10ml of 0.2% ropivacaine for 
next 72 hours. Control group did not receive any Transverse 
Abdominis Plane block. 
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 Both groups were given 1g of paracetamol infusion 
every 6 hourly and patient controlled analgesia with 
fentanyl. The total requirement of fentanyl was observed.  
Pain scores were analysed using Numerical Rating Scale, 
both at rest and during movement or cough. Any episodes of 
nausea, vomiting, sedation and complications due to 
catheter placement were also noted.  
 
 Median pain scores were  less in the Transverse 
Abdominis Plane block group when compared to control 
group from first post-op day onwards with a significant 
difference, with P values of <0.05. Mean fentanyl use was 
1237±145µg in control group whereas 664±134µg in 
Transverse Abdominis Plane group. 
 
 Thus this study concluded that Transverse Abdominis 
Plane block significantly reduced the requirement of 
fentanyl, and the complications associated with fentanyl 
usage. 
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2. McDonnell et al, 2008
(6)  
 They extensively carried out studies to find the 
efficacy of Transverse Abdominis Plane block in patients 
undergoing abdominal surgeries, caesarean sections and 
total abdominal hysterectomies.  
 
 In a prospective randomised control trial carried out 
on 25 parturients undergoing caesarean section, with in 
weight ranging from 42 – 65kg, they were randomly 
assigned into 2 groups – those undergoing Transverse 
Abdominis Plane  block and those not receiving Transverse 
Abdominis Plane Block, but only intravenous morphine as 
the sole analgesic agent.  
 
 Transverse Abdominis Plane group received about 
30ml of 0.25% bupivacaine and morphine was given at 
request while the other group received only intravenous 
morphine alone. VAS score, 24 hours opioid consumption 
and the time to first request for morphine were observed.  
 
 The mean morphine requirement was 18±14 mg in 
Transverse Abdominis Plane group and 66±26 mg in control 
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group. Time to first requirement was 220 minutes in 
Transverse Abdominis Plane  block whereas 90 minutes in 
control group, with a P value of <0.001. The dosage of drug 
used was well within 2 mg/kg body weight, without any 
signs or symptoms of bupivacaine toxicity. 
 
 They proved that Transverse Abdominis Plane block 
significantly reduced 48 hours morphine requirement . 
 
3. Belavy D et al, 2009
(27)  
 Conducted a randomised, controlled trial wherein 50 
patients were selected and randomised into two groups – 
Transverse Abdominis Plane group and PCA morphine 
group. These parturients underwent caesarean under 
subarachnoid block with heavy bupivacaine mixed with 
fentanyl and observed for the next 24 hours.   
 
 Pain scores, sedation, postoperative nausea and 
vomiting were also looked for. Mean VAS score was 10 in 
control group as compared to 7 in Transverse Abdominis 
Plane group, with significance value of 0.008.  Total 
morphine usage was 18mg in study group as compared to 
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31.5 mg in control group. Fewer patients needed antiemetic 
in Transverse Abdominis Plane group and no local 
complications were reported.  
 
4. Hyun Jun Shin et al, 2011
(21)  
 Conducted this study in which about 32 patients were 
randomised into 2 groups, one undergoing Transverse 
Abdominis Plane block and the other not receiving this 
block. 
 
 Patients were operated under general anaesthesia and  
block performed under ultrasonogram guidance after 
surgery and prior to extubation. About 20ml of 0.375% 
ropivacaine was given bilaterally. Postoperative pain relie f 
was given by intravenous Patient Controlled Analgesia 
containing ketorolac 90mg, sufentanyl 200µg and 
ramosetron 0.3mg in 120ml of NS totally for the first 24 
hours. Fentanyl was given when pain scores were very high.  
Primary outcome was NRS and total analgesic requirement 
for the next 48 hours.  
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 Pain scores were 3.6±2.3 at the end of 10 hours in 
control group whereas 2.3±2.4 in Transverse Abdominis 
Plane group with rest. Total analgesic requirements were 
62.5±35.4µg of fentanyl in control group and 20.3±20.9µg 
in Transverse Abdominis Plane group. 
 
 It was concluded that Transverse Abdominis Plane 
block has some opioid sparing action and reduced 
postoperative pain. It also improved patient satisfaction 
when multimodal analgesic regimen used and also no 
serious complications were associated with this method.  
 
5. Tery T Tan et al, 2012
(23)  
 They hypothesised that Transverse Abdominis Plane 
block reduces the 24 hour morphine consumption in 
parturients undergoing caeserean section by general 
anaesthesia instead of spinal anaesthesia. 
 
 40 patients were randomly allocated into 2 groups . 
The study group received 20ml of levobupivacaine 
2.5mg/ml bilaterally with ultrasound guidance at the end of 
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surgery. Control group did not receive any block and were 
given intravenous morphine through PCA.  
 
 They recorded the total morphine use for 24 hours, 
pain scores, sedation, nausea, vomiting and overall 
maternal satisfaction.  
 
 Results showed P<0.01 with the total 24 hr  morphine 
use in study group Vs control group and higher satisfaction 
in mothers. No difference was detected in between VAS 
score, sedation or postoperative nausea and vomiting.  
 
6. Jumaana M Baaj et al
(28)  
 They selected a group of 40 patients and randomised 
them into 2 groups, 20 in each group – one with Transverse 
Abdominis Plane block with saline and other with 
Transverse Abdominis Plane block with bupivacaine.  
 
 Both groups underwent surgery under subarachnoid 
block with 10mg of heavy bupivacaine and 20µg of 
fentanyl. At end of surgery, Transverse Abdominis Plane 
block performed with the use of Ultrasound probe . In 
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control group, 20ml of saline was injected bilaterally and in 
study group 20ml of 0.25% bupivacaine injected bilaterally. 
Both received intravenous PCA morphine for 24 hours.  
 
 Thus, 24 hr morphine consumption, VAS score, 
patient satisfaction, PONV, and sedation were considered.  
 
 24 hours morphine consumption was significantly 
reduced in bupivacaine group (26±5mg) than control group 
(63±5mg) and VAS scores were also better in bupivacaine 
group. Also patient satisfaction was improved and 
antiemetic use reduced in Transverse Abdominis Plane with 
bupivacaine group. 
 
7. Linda De Wendling, 2012
(7 )  
 Wrote an article based upon the personal experience 
of 3 physicians who were specialised in pain medicine. 
They underwent continuous Transverse Abdominis Plane   
block after caesarean section for 48 hrs and they 
experienced satisfactory and improved analgesia and early 
functional recovery. They had significantly reduced 
requirement of opioids. 
43 
 
8. Hebbard et al
(16)  
 First described the ultrasound guided approach in 
2007. He used real time ultrasound and identified the 
transverse abdominis plane by placing the probe over the 
Lower lumbar triangle of Petit. This was found to be very 
helpful in case of obese patients where the classical „pop ‟ 
feel of blind technique using anatomical landmarks will be 
misguiding or difficult to obtain 
 
9. Peterson et al
(9)  
 Cited about 7 randomised clinical trials in his review 
article where in Transverse Abdominis Plane block was 
given to surgery with incision below the level of umbilicus, 
using both blind as well as ultrasound guided method. All 
these proved that there was a reduction in 24hours 
morphine consumption and improved VAS scores. Also 
postoperative nausea and vomiting and sedation score 
related to opioid usage was significantly reduced.  
 
10. Owen et al, 2011
(23)  
 Conducted study on 16 cases and 18 controls 
undergoing caeserean section. He administered 20ml of 
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0,25% bupivacaine bilaterally and proved its supremacy 
over intravenous opioid usage . 
 
11. Karim Mukhtar, 2009
(25)  
 In his paper published in The Journal of New York  
School of Regional Anaesthesia describes in detail about 
the procedure of Transverse Abdominis Plane block, and 
about all the methods of performing it – blind technique 
and ultrasound guided, in detail.  
 
12. Sukhyanthi Kerai et al, 2011
(24)  
 They also conducted study based upon the previous 
studies and it was proved that Transverse Abdominis Plane 
block surely reduced the intake of opioids and thus 
extremely reduced the side effects related to opioid usage.  
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MATERIALS AND METHODS 
 
 This study was conducted at Institute of Obstetrics 
and Gynaecology, Egmore, attached to Madras Medical 
College, Chennai-600005, on 40 patients undergoing 
elective cesarean section. The study was conducted after 
getting Ethical committee clearance. Informed written 
consent was obtained from the patients included in the 
study. 
 
Study Design 
 This was a Prospective, Randomized, Double Blinded, 
Case Control study. Patients were divided into 2 groups of 
20 each. Only patients meeting the selection criteria were 
included in the study. Randomisation done by alternating 
patients to either Transverse Abdominis Plane group( Group 
T) or control group( Group C). 
 
Group T: Undergoing bilateral continuous Transverse 
Abdominis Plane block. 
Group C: Control group without Transverse Abdominis 
Plane block. 
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SELECTION OF CASES: 
Inclusion criteria: 
 Age          : 18 years and above 
 Weight    : BMI < 30 Kg/m2 
 ASA          : I & II 
 Surgery   : Elective 
 Who have given valid informed consent.  
 
Exclusion criteria:  
 Age >35yrs 
 Uncontrolled PIH 
 Multiple gestation 
 Short stature 
 Those not include in inclusion criteria  
 Those with abnormal coagulation profile  
 
MATERIALS REQUIRED: 
 Full resuscitation equipment  
 Patient monitoring (ECG, pulse oximeter, BP)  
 Antiseptic skin preparation and sterile gloves  
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 Ultrasound machine with a high frequency probe (10 -5 
MHz)  
 Ultrasound probe cover  
 Ultrasound gel  
 16 G Tuohy needle with catheter set-2; 20ml syringe  
 20 to 30 ml local anaesthetic 
 2 Infusion pumps   
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OUTCOMES MEASURED: 
Primary: 
 48 hrs opioid consumption 
Secondary: 
 Pain scores recorded on a visual analogue scale(VAS)  
 PONV, sedation 
 Maternal satisfaction 
 Complications related to the procedure or catheter 
placement 
 
 
ASSESSMENT OF PAIN USING VISUAL ANALOGUE 
SCORE 
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Visual Analog Scale (VAS) Score:  
 
 
Very           Hurts just     Hurts a    Hurts  even    Hurts a     Hurts as        
happy,        a l itt le bit .     l i tt le more.   more.       whole lot.   much as you  
no hurt .                                                                              can imagine.  
 
0       1        2        3        4        5        6       7       8      9     10 
No pain                                                         Severe pain  
 
MODIFIED RAMSAY SEDATION SCORE: 
Awake levels 
1. Anxious, agitated or both 
2. Co-operative oriented, tranquil 
3. Response to commands only 
 
Asleep levels 
1. Brisk response to loud auditory stimulus  
2. Sluggish response to loud auditory stimulus  
3. No response to loud auditory stimulus 
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STUDY METHOD: 
 All patients were assessed in our pre-anesthetic clinic. 
Patients with exclusion criteria were excluded. After 
getting informed consent, patients who satisfied our 
inclusion criteria were taken under our study.  
 Patients were divided into 2 groups of 20 each. 
Randomisation was done by alternating patients to 
either Transverse Abdominis Plane group (Group T) or 
control group (Group C). 
 Group T: Undergoing bilateral continuous 
Transverse Abdominis Plane  block      
 Group C:  Control group without Transverse 
Abdominis Plane block. 
 Inside the operation theatre, all basic monitors were 
connected (ECG, NIBP, SpO2, temperature 
monitoring). All basal parameters were noted.  
 Patient was given subarachnoid block under sterile 
aseptic precautions and monitored intraoperatively.  
 For Group T, Transverse Abdominis Plane block was 
done at end of surgery. 
 
51 
 
PROCEDURE: 
 Patient in supine position, ultrasound probe placed 
transverse to the abdominal wall between costal 
margin and iliac crest  
 Transverse abdominis plane reached using 16G 
Tuohy‟s needle with bevel facing superiorly  
 Correct placement of needle tip confirmed by 
injecting 5 – 10 ml saline Bolus dose of 15ml of 
0.25% bupivacaine administered. 
 Epidural catheter advanced cephalad up to 10cm 
(normal) - 15cm(obese) mark. 
 Needle removed and catheter connected to a bacterial 
filter. 
 Procedure repeated on opposite side.  
 Continuous infusion at the rate of 8 -10ml/hr for 72 hrs 
on each side.  
 In control group,  patients did not receive any 
Transverse Abdominis Plane  block 
  Standard Non steroidal anti  inflammatory agents were 
given every 8hrly in both groups. 
 Both received intravenous opioid Fentanyl on demand 
as intermittent boluses. 
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 Post operatively patient monitored in NPO ward. 
Various parameters like HR, Blood pressure (both systolic 
and diastolic), SPo2, Visual Analogue Scale (VAS) and 
Ramsay Sedation Score (RSS) were observed for 24 hours 
post operatively. Incidences of side effects were also noted. 
Injection Tramadol 50mg IV was used as rescue analgesia 
when pain score was more than 4 (i.e. VAS ≥4).  
 
STATISTICAL ANALYSIS: 
 Data were analysed using SSPS, WINDOWS 
VERSION 15 .Two sided independent student‟s  t tests to 
analyse continuous (quantitative) data, Fisher's exact test 
and chi-square test for categorical (qualitative) data were 
used. Pvalue<0.05 was considered as statistically 
significant. 
 
DEMOGRAPHIC DATA: 
 The two groups were compared with respect to their 
age, weight, and ASA status . 
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STATISTICS:  
Statistical analysis: 
DESIGN 
 This was a Prospective, Randomized, Double Blinded, 
Case Control study. Patients were divided into 2 groups of 
20 each. Only patients meeting the selection criteria were 
included in the study. Randomization done by alternating 
patients to either Transverse Abdominis Plane group  (Group 
T) or control group (Group C). 
 Group T:  Undergoing bilateral continuous Transverse 
Abdominis Plane block      
 Group C:  Control group without Transverse 
Abdominis Plane block. 
 
 Data obtained were analysed using SSPS, WINDOWS 
VERSION 15. Two sided independent student's t tests to 
analyse continuous (quantitative) data, Fisher's exact test 
and chi-square test for categorical data (qualitative) were 
used. P<0.05 was considered as statistically significant.   
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 Both groups were compared with respect to their age, 
weight, baseline systolic blood pressure , diastolic blood 
pressure, mean blood pressure, and heart rate. The level at 
the time of performing block, VAS scores over 48 hrs, the 
time for first requirement of fentanyl, total fentanyl 
consumption were noted and compared.  
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OBSERVATIONS AND RESULTS 
1. Demographic profile: AGE (in years):  
Group Number Mean(yrs) SD 
T 20 25.94 4.531 
C 20 25.50 3.687 
P value  0.734  (Not Significant) 
 
 The mean age in group T was 25.94 and in group C 
was 25.50. p value was 0.734, which was not statistically 
significant. Both groups were comparable in terms of age.  
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2.  Demographic profile: WEIGHT (in kg): 
Group No Mean(kg) SD 
A 20 55.56 5.338 
B 20 54.82 4.876 
P value  0.651 (Not Significant) 
 
 Weight of the patients in group T hed  mean value of 
55.56 and standard deviation of 5.34. In group C, mean 
value was 54.82 and standard deviation  4.88. The p value 
was 0.65, it was not statistically significant. Both groups 
were comparable in terms of weight.  
 
3. VAS SCORE: 
VAS score 
Group–C 
Mean ± sd 
Group-T 
Mean ± sd 
p-Value 
df=58 
15 min 1.05 ± 0.21 1.22 ± 0.55 0.172* 
30 min 1.41 ± 0.55 1.61 ± 0.92 0.382* 
2 hrs 3.64 ± 0.90 2.22 ± 0.81 0.000 
4 hrs 3.77 ± 0.69 2.28 ± 0.83 0.000 
6 hrs 3.00 ± 0.76 2.11 ± 0.83 0.001 
8 hrs 3.18 ± 0.73 2.28 ± 0.58 0.000 
12 hrs 3.09 ± 0.69 1.83 ± 0.71 0.000 
24 hrs 2.86 ± 0.71 1.67 ± 0.49 0.000 
     36 hrs 2.73 ± 0.55 1.78 ± 0.68 0.000 
     48 hrs 2.86 ± 0.71 1.56 ± 0.62 0.000 
    * Not Significant  
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 VAS scores were significantly lower in Transverse 
Abdominis Plane group than in control group. There was no 
difference in pain score at 0, 15 and 30minutes and was 
found to be statistically not significant (p>0.05).  
 
 At end of 24
th
 hr, the mean VAS score in Transverse 
Abdominis Plane group was 1.67±0.485 and in Control 
group was 2.86±0.774; there was statistical  significant 
difference in both groups (p<0.000) 
 
 At 48 hours, the mean VAS score in Transverse 
Abdominis Plane  group was 1.56±0.616 and in Control 
group  was 2.86±0.710 and was also found to be 
statistically significant (p<0.000).  
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4. SENSORY LEVEL OF BLOCKADE (dermatome): 
GROUP T4 T5 T6 T7 T8 T9 T10 T11 
A 1 0 6 2 6 1 3 1 
B 1 1 2 2 5 7 2 0 
 
 
 
5. HEART RATE: 
TIME GROUP N   MEAN 
(per min) 
STD. 
DEV 
P 
VALUE 
HR_15m 
  
Control 20 83.45 12.312 
0.963 
Study 20 83.28 11.103 
HR_30m 
  
Control 20 84.27 12.456 
0.886 
Study 20 84.78 8.928 
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HR_2h 
  
Control 20 87.14 10.366 
0.669 
Study 20 85.72 10.249 
HR_4h Control 20 84.77 10.547 
0.773 
  Study 20 85.67 8.458 
HR_6h Control 20 80.09 9.961 
0.324 
  Study 20 82.83 6.653 
HR_8h Control 20 79.41 8.330 
0.048 
  Study 20 84.83 8.382 
HR_12h Control 20 80.00 6.332 
0.235 
  Study 20 82.61 7.342 
HR_24h Control 20 77.82 8.238 
0.374 
  Study 20 80.17 8.176 
HR_36h Control 20 78.91 8.847 
0.668 
  Study 20 80.00 6.642 
HR_48h Control 20 78.36 6.870 
0.970 
  Study 20 78.44 6.428 
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6. MEAN ARTERIAL PRESSURE: 
TIME GROUP N MEAN 
(mm Hg) 
STD.DEV P 
VALUE 
MAP_15m Control 20 82.1667 7.30568 0.197 
   Study 20 78.3889 10.83582 
MAP_30m Control 20 83.1515 6.59383 
0.187 
  Study 20 86.6296 9.71616 
MAP_2h Control 20 85.0000 8.08814 
0.194 
  Study 20 88.5370 8.81557 
MAP_4h Control 20 85.6364 8.93889 
0.315 
  Study 20 88.7778 10.57374 
MAP_6h Control 20 85.0303 8.95072 
0.283 
  Study 20 88.1852 9.29630 
MAP_8h Control 20 84.3333 7.38295 
0.487 
  Study 20 85.9630 7.21100 
MAP_12h Control 20 83.3939 7.52466 
0.572 
  Study 20 84.8333 8.44223 
MAP_24h Control 20 82.6818 7.02714 
0.746 
  Study 20 83.3889 6.56217 
MAP_36h Control 20 82.0606 6.05411 
0.751 
  Study 20 82.7037 6.63807 
MAP_48h Control 20 82.4242 6.24896 
0.424 
  Study 20 84.0000 6.00218 
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 There was no significance in heart rate and also mean 
blood pressure of both groups. Also the intervariability was 
insignificant. 
 
7. TOTAL FENTANYL REQUIREMENT: 
GROUP N MEAN(µg) STD.DEV P VALUE 
GROUP C 20 384.77 105.351 0.000 
 GROUP T 20 116.67 32.084 
 
 The total 48 hours Fentanyl consumption in Group C 
was 384.77+105.35 μg, where as in Group T it was 
116.67+32 μg, with P value of < 0.000, which was 
statistically highly significant.  
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8. TIMING OF FIRST DOSE: 
GROUP N MEAN ± STD.DEV(MIN) 
CONTROL 20 54.77 ± 36.76 
STUDY 20 136.4 ± 24.54 
P value 0.000 
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 The time for requirement of first analgesic dose was 
significantly prolonged with the use of TAP block. The 
mean time for requirement was 55+37 mins in Group C, 
where is prolonged to 136+25 mins in Group T. P value was 
<0.000. 
  
9. SEDATION (modified Ramsay sedation score): 
SEDATION 0 1 2 3 4 
Grp T 1 9 10 0 0 
Grp C 0 0 9 8 3 
P value 0.000 (significant) 
 
 
 High sedation scores were seen in study group, 
whereas alertness was maintained in the Transverse 
Abdominis Plane group. 
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10. SIDE EFFECTS  
Side effects Group T Group C 
Bradycardia 0 0 
Sedation(>3) 0 3 
Respiratory depr 0 5 
Nausea&Vomiting 0 2 
Hypotension 0 0 
 
 
 
None of the patients in Group T developed any side 
effects. P value was 0.000, which was highly statistically 
significant. In Group C, 2 patients developed vomiting, 5 
patients developed respiratory depression (defined as 
respiratory rate <12/minute)  
 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
PONV Sedation Resp dep Brady Hypo
Grp T
Grp C
65 
 
DISCUSSION 
 
 The role of Transverse Abdominis Plane Block in 
major abdominal surgeries is not fully defined. So our 
study demonstrates its probable efficacy in patients 
undergoing lower segment caesarean section who have a 
below umbilicus pfannensteil incision, in terms of reducing 
pain scores and opioid usage for the first 48 hours. The 
posterior approach described by Hebbard et al
(16 )
 was 
followed in our study.  
 
Technical problems encountered in our study were  
 Difficulty to hold the transducer probe  
 Use of large volume of saline to confirm space  
 Leakage of local anaesthetic solution through the 
wound site 
 Soiling of the dressing 
 Chances of dislodgment of catheter.  
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 This was prevented by getting help of an assistant and 
correct visualisation of tip of the needle. Other problems 
were partly by subcutaneous tunnelling.  
 
 In our study, the demographic profile was comparable 
with respect to mean age, body weight and ASA physical 
status. We did bilateral Transverse Abdominis Plane block 
in the group T and gave 15 to 20 ml of 0.25% bupivacaine 
according to the patient weight and continuous infusion on 
both sides were started at 10 ml/ hr of 0.125% bupivacaine. 
They received the usual doses of NSAIDS 8 hourly and 
were given fentanyl on demand whenever patient 
complained of pain. The pain scores and the total 
requirement of fentanyl of both groups were observed.  
 
Pain scores 
 Results of our study showed that Transverse 
Abdominis Plane block, significantly reduced VAS scores 
over 48hour period. Though the initial 2hours produced 
similar scores, corresponding to the period of wearing off 
of spinal analgesia, the scores were significantly reduced 
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since the second hour postoperatively.  This finding was 
correlating with studies done by 
 
1. Rao et al
(5)
 did study of patients undergoing major 
abdominal surgeries under general anaesthesia and 
performed Transverse Abdominis Plane Block in these 
patients. His study observed that pain scores were 
insignificant at 0 hours and 1
s t
 hours after surgery. Pain 
was significantly less on day1, on cough; day2, both on 
coughing and on rest and insignificant scores followed on 
day 3. 
 
2. Teny T Tan et al
(23)
 who also conducted studies on 
patients undergoing caesarean section under general 
anaesthesia and Transverse Abdominis Plane  block given 
at end of surgery. They did not do this block under 
ultrasound guidance. Although there was a reduction in the 
scores, they detected no significance in VAS scores in their 
study. 
 
3. McDonnell et al
(6)
 reported a significant reduction in 
VAS score over 48 hrs. They conducted study in which the 
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patients received spinal anaesthesia for caesarean section. 
Their study differed from ours in that they used ropivacaine 
instead of bupivacaine and morphine instead of fentanyl. At 
some points however the VAS scores was lower in study 
group. 
 
4. Hyun Jung Shin et al
(21)
 used 0.375% ropivacaine in 
single shot Transverse Abdominis Plane block for patients 
undergoing gynaecological surgeries through below 
umbilicus transverse incision. Intravenous pethidine and 
fentanyl were used through PCA method.  Over the next 48 
hours they observed a P value of <0.05 in Transverse 
Abdominis Plane group as compared with control group.  
 
5. Belavy D et al
(27)
 observed no significant changes in the 
VAS scores in their study. Their study differed from ours in 
that they received fentanyl 15µg along with 0.5% 
hyperbaric bupivacaine for subarachnoid blocks. Regularly 
paracetamol 1g was given 4 hourly along with ibuprofen 
400mg tds and PCA morphine given. It was however 
observed that their patients were able to mobilize within 24 
hrs postoperatively.  
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6. Borglum et al
(9)
 demonstrated effective pain 
management and thus quicker mobilisation and discharge 
from PACU in their study on patients undergoing major 
abdominal surgeries who were given bilateral 4 pointed 
Transverse Abdominis Plane block. 
 
48 Hour Fentanyl Consumption: 
 In our study we found out that the total opioid 
consumption over 48 hours was significant statistically.  In 
controls, the mean requirement was 384.77±105.35µg 
whereas it was 116.67±32.08µg in case of Transverse 
Abdominis Plane block group. P value was about 0.000. 
This finding was consistent with the following studies.  
 
1. Rao et al
(5)
 showed significant difference at 1
s t
 hour and 
on postoperative day 1 and 2 (control – 1237±146; 
Transverse Abdominis Plane – 664 ± 134µg on day 1), 
whereas it was insignificant on day 3(control – 661±237; 
Transverse Abdominis Plane – 609±161µg ).  
 
2. Teny T Tan et al
(23)
 observed a significant reduction in 
morphine usage for the initial 24 hours. Whose mean values 
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were 31.4±3.1mg in control whereas 12.3±2.6mg in 
Transverse Abdominis Plane group, with a P value of 
<0.001. 
 
3. Bharthi et al
(23)
 showed a significant reduction of 24 
hour morphine consumption; in controls the mean was 
17.55 ± 5.78 mg and in TRANSVERSE ABDOMINIS 
PLANE  group it was 6.45±3.26mg with P value of 
<0.0001. 
 
4. Hivelin et al
(23)
 demonstrated that the morphine 
requirement was in the range of 36 – 46mg in control group 
whereas 27 – 38 mg in study group. The P value was 
<0.0057. their study differed in that they observed the 
patients only for initial 24hrs.  
 
5. There was no significant difference in 24 hr opioid 
consumption in the study by Griffith et al
(23)
 where he 
performed ultrasound guided Transverse Abdominis Plane 
blocks with ropivacaine and saline. They concluded that the 
high incidence of obesity in their study group and thus 
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technical failures might have lead to such a negative 
observation. 
 
6. Baaj et al
(23)
 observed a significant(P value < 0.05%) 
reduction in 24 hr morphine consumption. Their control 
group received Transverse Abdominis Plane block with 
saline whereas the study group received bupivacaine. The 
morphine requirements were 63±5mg in saline group and 
26±5mg in bupivacaine group.  
 
7. Mc Donnell et al
(6)
, who conducted study over patients 
undergoing caesarean receiving Transverse Abdominis 
Plane block compared with placebo, the 48 hr morphine 
requirement was 66±26mg in control Vs 18±14mg 
Transverse Abdominis Plane group who received 
ropivacaine. 
 
8. The study conduted by Belavy et al
(27)
 noted the total 
amount of morphine used over 24hrs. Placebo group had a 
mean morphine need of 31.5mg which was significant 
statistically as morphine requirement was 18mg in study 
group. 
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9. Hyun Jung Shin et al
(21)
 did ultrasound guided 
TRANSVERSE ABDOMINIS PLANE  block in patients 
undergoing gynaecological surgeries under general 
anaesthesia and concluded that this block reduced fentanyl 
requirement from 62.5±35µg in control to 20.3±20.9µg in 
study group. 
 
Time to rescue analgesia: 
 Our study demonstrated a signif icant reduction in the 
first dose timing of fentanyl in the study group. Control 
group took about a mean of 55minutes whereas 135 min in 
Transverse Abdominis Plane block group with P value 
<0.000. 
 
Belavy et al
(27)
 observed that time for the first demand of 
analgesia was 3hrs in Transverse Abdominis Plane group 
whereas 2hrs in control group. No other study group 
patients were having complications related to the procedure 
and were well satisfied.  
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Side effects – PONV, Sedation, Pruritis, Respiratory 
depression: 
 The incidence of postoperative nausea and vomiting 
was absent in the study group while two cases in the 
control group had PONV. We also noted that about 5 
patients had mild decrease in respiratory rate in control 
group. There was no pruritis in both groups . Sedation 
scores at the end of 48 hours was found to be high in 
control group than in Transverse Abdominis Plane group.  
 
 Though McDonnell et al
(6)
 observed no significant 
changes in incidence of postoperative nausea and vomiting, 
there was significance in sedation scores of both groups 
wherein they found about 36% incidence in the controls 
whereas it was nil in Transverse Abdominis Plane  group. 
Thus maternal satisfaction was better in the Transverse 
Abdominis Plane group. The trial conducted by  Belavy et 
al
(27)
 showed significant reduction in PONV in Transverse 
Abdominis Plane group, but pruritis and sedation cores 
were similar in both groups . Tery Tan et al
(23)
 showed that 
their results had no changes in incidence of sedation and no 
respiratory depression was found . Katrina et al  reported 
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nil vomiting and complications pertaining to catheter 
placement. Another case report also noted absence of 
PONV in TRANSVERSE ABDOMINIS PLANE given 
patients. Also Jumana et al
(28)
 also reported fewer 
incidences of nausea and vomiting. 
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SUMMARY 
 
 Transverse Abdominis Plane block is an efficient and 
safe adjuvant to multimodal postoperative analgesia in 
abdominal surgeries, especially with incisions below 
umblicus. Patients who are contraindicated for long acting 
or highly sensitive to opioids can receive this block as an 
adjuvant to the usual analgesic regimen for greater comfort. 
Coagulation profile is an area of uncertainity which 
requires further studies to prove its efficacy.  Also there are 
no major neurovascular structures near the area of block 
which is of great advantage. 
 
 Some studies have reported complications of 
Transverse Abdominis Plane block. One case was diagnosed 
with hemoperitoneum following liver trauma due to 
subcostal block. Another study reported large intestinal 
puncture and hematoma following Transverse Abdominis 
Plane block. Also there occured intraperitoneal injections, 
transient femoral nerve palsy. Use of Ultrasound certainly 
minimises these complications.  
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 The physiological changes following epidural 
analgesia due to sympathetic blockade is completely absent 
in Transverse Abdominis Plane block. The advantages of 
epidural, like – reduction in incidence of thromboembolism, 
postoperative pneumonia, intra operative blood loss, 
reduced stress response and stress induced 
immunosuppression – are not proved to be with the use of 
Transverse Abdominis Plane block. So Transverse 
Abdominis Plane block is superior in use as a supplement to 
multimodal postoperative analgesia and in reducing total 
opioid consumption. 
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CONCLUSION 
 
 Thus Transverse Abdominis Plane block can be used 
in cases where in central neuro axial blockade is 
contraindicated. However only somatic pain can be blocked 
with this technique and fentanyl is required to block 
visceral pain. So it can be used as an adjuvant to 
multimodal method of analgesia, thereby reducing the total 
requirement of opioid and its adverse effects.  
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ANTIPLAGARISM SCREEN SHOT 
 
 
PATIENT CONSENT FORM 
 
 
Study Title: Prospective randomised control study for 
evaluating the efficacy of ultrasound guided  continuous 
transverse abdominis plane block in patients undergoing 
lower segment caesarean section for postoperative 
analgesia. 
 
Study centre:  Department of Anaesthesiology,                                                                                                                                            
                        Institute of Obstetrics and Gynaecology,  
   Chennai 
 
Participant name:          
Age/Sex:                                 
I.P.No: 
 
 I confirm that I have understood the purpose of 
procedure for the above study. I have the opportunity to ask 
the question and all my questions and doubts have been 
answered to my satisfaction. 
 
 I have been explained about the pitfall in the 
procedure. I have been explained about the safety,  
advantage and disadvantage of the technique.  
 
 I understand that my participation in the study is 
voluntary and that I am free to withdraw at anytime without 
giving any reason.  
 
 I understand that investigator,  regulatory authorities 
and the ethics committee will not need my permission to 
look at my health records both in respect to current study 
and any further research that may be conducted in relation 
to it, even if I withdraw from the study. I understand that 
my identity will not be revealed in any information released 
to third parties or published, unless as required under the 
law.  I agree not to restrict the use of any data or result s 
that arise from the study.  
 
Time:          
Date:                
Signature / Thumb impression of patient  
 
 
Place:      Patient Name 
 
Signature of the investigator:  
 
Name of the investigator:  
 
  
INFORMATION TO THE PARTICIPANTS 
 
INVESTIGATOR: 
NAME OF PARTICIPANT: 
TITLE: 
 You are invited to take part in this research study. We 
have got approval from the ethical committee.  You are 
asked to participate because you satisfy the eligibility 
criteria. We want to study the efficacy of ultrasound guided 
continuous TAP block for cesarean section, as postoperative 
analgesia. 
 
PURPOSE OF THE STUDY: 
 The requirement of fentanyl for postoperative 
analgesia is high following cesarean sections. This study 
evaluates the efficacy of TAP block to reduce the 
postoperative requirements of morphine. 
 
THE STUDY DESIGN: 
 All the patients in this study will be divided into two 
groups. At the end of surgery,  
Group A:  Receive ultrasound guided bilateral TAP block, 
with 0.25% bupivacaine 
Group B:  No TAP block and followed by intravenous 
fentanyl on demand. 
 
 All these patients are shifted to postoperative ward for 
observation and postoperative pain relief management.  
 
BENEFITS: 
- Total fentanyl consumption is reduced and thus its 
side effects like nausea, vomiting, sedation, pruritis 
are reduced.  
- Better patient satisfaction.  
 
 
Time: 
 
Date:                                                                 
Signature / thumb impression of the patient  
 
Place: 
 
Signature of investigator:     Patient Name 
 
 
Name of the investigator:  
 
PROFORMA 
 
Name:    Age:   Sex: 
 
Weight:    IP.No: 
 
Diagnosis: 
 
Procedure: 
 
Anaesthetic Plan:     ASA 
 
Level of blockade at the end of surgery:  
Time BP Pulse SpO2  VAS Side Effects  
15 mins      
30 mins      
2 hrs       
4 hrs       
6 hrs       
8 hrs       
12 hrs       
24 hrs       
36 hrs       
48 hrs       
   
Rescue Analgesia:  
Time of Requirement  Dose of Fentanyl  
  
  
  
  
  
  
  
  
  
  
 
MASTER CHART 
GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age Weight Diagnosis ASA Group 
Level of 
Blockade VAS SCORE 
At End of 
Surgery 15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
1 Arthi 23 62 PREV LSCS 2 1 T8 1 1 3 1 1 2 2 2 1 1 
2 Sathya 22 51 PREV LSCS 2 1 T6 1 1 3 2 2 3 3 2 2 2 
3 Devi 26 58 CPD 2, POSTDATED 2 1 T6 1 1 2 3 2 2 1 2 1 2 
4 Abirami 21 52 CPD 1, FAILED ACCELERATION 2 1 T8 1 1 2 3 2 2 1 1 2 1 
5 Hemapriya 23 50 PREV LSCS 2 1 T7 1 2 2 1 1 2 1 2 1 1 
6 Velva 30 59 CPD IN LABOUR 2 1 T10 2 3 2 2 1 2 2 1 2 1 
7 Kavitha 29 65 BOH 2 1 T8 1 1 3 2 3 4 2 2 2 2 
8 Jeyanthi 22 58 PREV LSCS, CPD 2 1 T10 2 3 1 2 4 3 2 2 1 1 
9 Jothi 28 50 PREV 2 LSCS 2 1 T11 3 4 2 3 2 3 2 1 2 3 
10 Durga 21 54 PRIMI, POSDATED 2 1 T6 1 1 1 3 2 2 2 1 2 2 
11 Velvizhi 32 60 PREV LSCS 2 1 T9 1 2 1 1 2 2 3 2 1 1 
12 Rukmani 35 60 ELDERLY PRIMI, FI 2 1 T6 1 1 2 2 3 2 1 1 2 1 
13 Sathya 21 48 FAILED INDUCTION 2 1 T8 1 2 2 2 1 2 1 2 1 1 
14 Latha Ramesh  26 52 PRIMI,CPD IN LABOUR 2 1 T8 1 1 3 2 2 2 1 1 2 1 
15 Jennifer 21 63 PRIMI, BREECH 2 1 T6 1 1 2 4 3 2 2 2 3 2 
16 Revathy 33 50 SEVERE OLIGOHYDRAMNIOS 2 1 T8 1 2 4 3 2 2 3 2 2 2 
17 Devi 26 58 PREV LSCS 2 1 T4 1 1 2 3 2 2 2 2 3 2 
18 Annapoorani 28 50 PRIMI BREECH 2 1 T7 1 1 3 2 3 2 2 2 2 2 
19 Dhanalakshmi 32 50 PRIMI, CPD, FETAL DISTRESS 2 2 T10 2 2 3 5 4 3 3 2 3 3 
20 Divya 22 60 PREV LSCS 2 2 T6 1 1 4 3 2 3 3 2 2 2 
 
 
 GROUP C – NO TAP BLOCK 
S 
No Name Age Weight Diagnosis ASA Group 
Level of 
Blockade VAS SCORE 
At End of 
Surgery 15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
21 Gomathi 26 66 CPD, PLACENTA PRAEVIA 3 2 T9 1 2 4 3 3 2 2 3 4 3 
22 Devi 25 54 PRIMI, MSL 2 2 T9 1 1 3 3 2 4 2 2 2 2 
23 Girija 25 60 PREV LSCS 2 2 T7 1 1 4 3 2 3 3 2 2 3 
24 Manimegalai 22 60 CPD IN LABOUR 2 2 T8 1 1 3 4 3 2 2 3 2 3 
25 Sangeetha 20 52 PREV LSCS, 2 2 T10 1 2 4 3 3 3 3 2 3 2 
26 Sathya 25 48 PRIMI, MSL 2 2 T9 1 2 3 3 2 2 2 2 2 2 
27 Eromiya 24 56 CPD, BICORNUATE UTERUS 2 2 T4 1 1 2 4 2 2 3 2 2 2 
28 Nagammal 23 50 PRIMI, BREECH 2 2 T7 1 2 4 3 3 4 3 3 3 3 
29 Nithya 25 50 PREV LSCS, MSL 2 2 T8 1 1 3 4 3 4 4 3 3 3 
30 Lakshmi 32 55 PRIMI, CPD 2 2 T6 1 1 3 5 4 4 3 4 3 3 
31 Ramya 21 50 FAILED INDUCTION 2 2 T8 1 1 5 4 4 3 3 4 3 4 
32 Ramya 25 55 PREV LSCS 2 2 T9 1 2 4 4 3 4 4 3 3 3 
33 Shakila 23 50 PREV LSCS 2 2 T10 1 2 5 4 3 4 4 3 3 4 
34 Poongavanam 28 58 PREV LSCS 2 2 T9 1 1 4 3 4 3 3 3 3 3 
35 Sargunam 35 50 ELDERLY PRIMI, MSL 2 2 T6 1 1 5 4 3 4 4 3 3 4 
36 Asha 25 60 PREV LSCS 2 2 T5 1 1 2 4 3 4 3 4 3 3 
37 Priya 23 60 PRIMI, FAILED IND 2 2 T9 1 2 4 5 4 3 4 4 3 4 
38 Rani 28 50 PRIMI, FD 2 2 T8 1 1 3 4 4 3 3 4 3 2 
39 Magdalin Mary 26 54 PREV LSCS 2 2 T8 1 1 3 4 2 3 3 2 2 3 
40 Datchayini 26 58 PREV LSCS 2 2 T9 1 2 5 4 3 3 4 3 3 2 
 GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age 
RESCUE ANALGESIA SIDE EFFECTS 
Total Dose-
Fentanyl (μg) 
Timing of First 
Dose (mins) PONV BRADY 
RESP 
DEP Pruritis Sedation at end of 48 hrs Hypotension 
1 Arthi 23 
100 120 0 0 0 0 2 0 
2 Sathya 22 
125 180 0 0 0 0 2 0 
3 Devi 26 
150 100 0 0 0 0 1 0 
4 Abirami 21 
150 120 0 0 0 0 2 0 
5 Hemapriya 23 
175 120 0 0 0 0 1 0 
6 Velva 30 
75 145 0 0 0 0 2 0 
7 Kavitha 29 
100 160 0 0 0 0 3 0 
8 Jeyanthi 22 
100 160 0 0 0 0 0 0 
9 Jothi 28 
100 140 0 0 0 0 1 0 
10 Durga 21 
125 100 0 0 0 0 2 0 
11 Velvizhi 32 
100 120 0 0 0 0 2 0 
12 Rukmani 35 
125 140 0 0 0 0 2 0 
13 Sathya 21 
175 165 0 0 0 0 1 0 
14 Latha Ramesh  26 
150 140 0 0 0 0 1 0 
15 Jennifer 21 
100 125 0 0 0 0 2 0 
16 Revathy 33 
75 120 0 0 0 0 1 0 
17 Devi 26 
75 120 0 0 0 0 2 0 
18 Annapoorani 28 
100 180 0 0 0 0 1 0 
19 Dhanalakshmi 32 
125 180 0 0 0 0 2 0 
20 Divya 22 
100 120 0 0 0 0 1 0 
 
GROUP C – NO TAP BLOCK 
S 
No Name Age 
RESCUE ANALGESIA SIDE EFFECTS 
Total Dose-
Fentanyl (μg) 
Timing of First 
Dose (mins) PONV BRADY 
RESP 
DEP Pruritis Sedation at end of 48 hrs Hypotension 
21 Gomathi 26 425 30 0 0 0 0 2 0 
22 Devi 25 300 25 0 0 0 0 3 0 
23 Girija 25 325 60 0 0 0 0 3 0 
24 Manimegalai 22 375 45 0 0 0 0 4 0 
25 Sangeetha 20 400 90 0 0 1 0 2 0 
26 Sathya 25 425 60 0 0 0 0 3 0 
27 Eromiya 24 525 75 1 0 0 0 3 0 
28 Nagammal 23 325 60 1 0 1 0 3 0 
29 Nithya 25 400 45 0 0 0 0 2 0 
30 Lakshmi 32 450 30 0 0 0 0 3 0 
31 Ramya 21 450 45 0 0 0 0 2 0 
32 Ramya 25 520 60 0 0 1 0 3 0 
33 Shakila 23 480 25 0 0 1 0 3 0 
34 Poongavanam 28 360 45 0 0 0 0 4 0 
35 Sargunam 35 420 40 0 0 0 0 2 0 
36 Asha 25 400 35 0 0 0 0 2 0 
37 Priya 23 380 15 0 0 0 0 2 0 
38 Rani 28 440 55 0 0 0 0 4 0 
39 Magdalin Mary 26 460 25 0 0 0 0 2 0 
40 Datchayini 26 380 40 0 0 1 0 2 0 
 GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age 
VAS SCORE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
1 Arthi 23 
84 87 92 87 80 78 89 84 89 78 
2 Sathya 22 
72 74 89 90 88 88 78 72 72 80 
3 Devi 26 
92 86 96 92 86 87 82 80 76 72 
4 Abirami 21 
74 72 86 88 82 84 81 72 80 80 
5 Hemapriya 23 
88 84 80 76 72 80 90 90 92 85 
6 Velva 30 
74 96 89 82 84 88 82 80 78 76 
7 Kavitha 29 
108 100 99 98 88 106 99 98 86 88 
8 Jeyanthi 22 
80 84 76 84 98 88 96 76 85 86 
9 Jothi 28 
99 96 82 84 82 76 80 82 84 82 
10 Durga 21 
70 69 72 79 74 74 78 62 76 68 
11 Velvizhi 32 
88 86 72 74 70 78 72 75 76 70 
12 Rukmani 35 
92 94 86 88 82 89 76 78 82 80 
13 Sathya 21 
74 82 88 84 82 76 74 78 70 82 
14 Latha Ramesh  26 
84 82 90 88 87 90 82 78 80 76 
15 Jennifer 21 
96 88 90 102 88 98 90 92 90 88 
16 Revathy 33 
82 92 106 98 80 82 80 78 72 74 
17 Devi 26 
72 82 86 74 88 76 78 82 80 80 
18 Annapoorani 28 
70 72 64 74 80 89 80 86 72 67 
19 Dhanalakshmi 32 
88 96 92 102 88 76 72 70 76 74 
20 Divya 22 
80 76 80 86 84 82 89 76 78 78 
 
 GROUP C – NO TAP BLOCK 
S 
No Name Age 
VAS SCORE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
21 Gomathi 26 64 68 72 80 76 72 68 67 68 70 
22 Devi 25 78 82 84 79 76 82 88 86 84 82 
23 Girija 25 82 88 86 84 82 80 76 76 72 69 
24 Manimegalai 22 78 82 88 89 74 68 76 80 82 88 
25 Sangeetha 20 98 90 96 80 84 82 80 80 84 84 
26 Sathya 25 88 84 98 98 92 84 78 80 85 84 
27 Eromiya 24 78 72 80 88 80 82 80 86 84 74 
28 Nagammal 23 69 70 64 72 74 72 80 68 72 70 
29 Nithya 25 78 64 70 89 70 86 88 74 62 74 
30 Lakshmi 32 80 82 96 98 88 88 84 82 90 76 
31 Ramya 21 76 78 88 72 76 74 78 86 86 82 
32 Ramya 25 82 78 86 78 72 82 84 82 80 91 
33 Shakila 23 88 92 98 89 64 80 82 78 77 78 
34 Poongavanam 28 85 106 96 92 90 82 67 72 78 82 
35 Sargunam 35 84 86 98 88 76 82 80 82 86 78 
36 Asha 25 82 76 73 78 82 87 78 74 78 80 
37 Priya 23 112 108 100 99 106 92 92 89 88 86 
38 Rani 28 68 78 94 88 82 78 84 88 92 82 
39 Magdalin Mary 26 82 88 94 80 86 84 80 82 78 80 
40 Datchayini 26 116 110 84 56 60 52 76 54 56 62 
 
 GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age 
HEART RATE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
1 Arthi 23 
110 116 124 112 110 116 108 110 120 124 
2 Sathya 22 
116 120 105 110 116 112 112 107 119 120 
3 Devi 26 
132 136 124 120 132 130 126 112 125 126 
4 Abirami 21 
128 122 132 134 128 120 117 128 120 116 
5 Hemapriya 23 
108 112 102 98 98 100 98 104 102 100 
6 Velva 30 
142 128 132 126 120 116 120 118 124 108 
7 Kavitha 29 
124 116 114 132 136 122 108 116 110 114 
8 Jeyanthi 22 
108 124 128 132 124 120 118 120 104 112 
9 Jothi 28 
98 118 102 96 100 108 104 96 98 96 
10 Durga 21 
104 112 108 128 130 116 108 114 118 120 
11 Velvizhi 32 
119 124 120 112 110 110 120 112 114 110 
12 Rukmani 35 
100 112 128 112 110 104 100 98 98 102 
13 Sathya 21 
128 124 128 132 120 118 124 112 110 120 
14 Latha Ramesh  26 
106 122 106 110 112 110 98 96 98 114 
15 Jennifer 21 
100 114 112 118 124 122 108 102 100 102 
16 Revathy 33 
104 132 128 126 122 120 120 110 112 108 
17 Devi 26 
98 104 116 120 102 100 104 106 106 112 
18 Annapoorani 28 
106 102 108 110 116 110 104 110 112 120 
19 Dhanalakshmi 32 
116 112 128 140 126 124 123 120 114 116 
20 Divya 22 
118 116 115 112 110 110 112 110 108 110 
 
 GROUP C – NO TAP BLOCK 
S 
No Name Age 
HEART RATE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
21 Gomathi 26 102 116 126 128 130 132 132 120 126 128 
22 Devi 25 122 120 120 110 116 118 112 104 108 116 
23 Girija 25 108 112 123 128 120 118 108 112 106 108 
24 Manimegalai 22 112 112 116 130 122 124 118 112 114 112 
25 Sangeetha 20 106 104 116 124 122 126 114 112 116 108 
26 Sathya 25 110 114 112 116 110 104 106 112 112 110 
27 Eromiya 24 112 112 110 104 110 112 112 116 112 112 
28 Nagammal 23 106 110 108 108 110 108 116 112 102 108 
29 Nithya 25 96 102 104 98 98 96 98 100 98 94 
30 Lakshmi 32 114 110 116 112 130 128 124 123 112 110 
31 Ramya 21 112 132 120 120 110 118 115 108 108 110 
32 Ramya 25 100 108 112 106 108 102 100 100 110 108 
33 Shakila 23 110 104 108 106 120 110 106 108 110 126 
34 Poongavanam 28 99 106 108 110 124 122 114 110 108 112 
35 Sargunam 35 118 104 106 110 110 110 108 112 118 110 
36 Asha 25 100 112 98 96 98 112 102 98 100 100 
37 Priya 23 116 112 108 110 116 120 118 110 106 112 
38 Rani 28 108 116 118 112 104 100 108 108 100 112 
39 Magdalin Mary 26 116 110 106 112 124 128 118 116 116 112 
40 Datchayini 26 110 112 112 120 124 124 126 128 120 116 
 
 GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age 
SYSTOLIC BLOOD PRESSURE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
1 Arthi 23 
64 70 72 68 68 54 60 68 72 76 
2 Sathya 22 
72 74 76 76 70 75 72 78 68 66 
3 Devi 26 
75 86 84 85 80 80 84 84 82 86 
4 Abirami 21 
65 72 88 84 80 80 74 76 72 70 
5 Hemapriya 23 
48 52 64 56 62 56 58 62 60 62 
6 Velva 30 
82 86 86 76 72 78 76 72 68 68 
7 Kavitha 29 
71 67 62 84 82 74 72 68 66 68 
8 Jeyanthi 22 
56 87 82 90 80 79 86 82 78 67 
9 Jothi 28 
48 78 72 64 68 74 72 74 68 64 
10 Durga 21 
62 68 74 72 88 76 68 62 70 68 
11 Velvizhi 32 
67 58 74 78 78 74 86 78 82 80 
12 Rukmani 35 
51 62 72 66 68 72 68 62 60 76 
13 Sathya 21 
68 82 86 94 82 78 80 72 68 74 
14 Latha Ramesh  26 
58 78 72 66 68 72 66 68 60 67 
15 Jennifer 21 
62 64 72 76 84 68 72 70 70 68 
16 Revathy 33 
56 72 78 76 80 78 72 68 68 64 
17 Devi 26 
48 62 62 68 68 70 72 68 68 70 
18 Annapoorani 28 
48 52 56 54 48 56 54 54 58 62 
19 Dhanalakshmi 32 
72 76 74 84 74 72 78 75 78 76 
20 Divya 22 
68 66 68 64 64 68 69 62 66 62 
 
 GROUP C – NO TAP BLOCK 
S 
No Name Age 
SYSTOLIC BLOOD PRESSURE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
21 Gomathi 26 82 78 84 84 88 82 78 76 74 73 
22 Devi 25 84 80 78 78 84 68 66 63 64 68 
23 Girija 25 68 72 78 84 80 78 78 76 74 72 
24 Manimegalai 22 68 76 74 70 62 68 64 63 64 66 
25 Sangeetha 20 78 76 80 80 82 74 72 74 76 70 
26 Sathya 25 64 64 66 68 62 64 64 68 66 68 
27 Eromiya 24 56 56 58 62 62 60 66 64 68 64 
28 Nagammal 23 68 74 78 74 76 74 76 70 72 72 
29 Nithya 25 56 54 52 56 60 56 56 54 52 53 
30 Lakshmi 32 78 86 82 78 78 74 74 76 76 78 
31 Ramya 21 62 54 58 68 80 64 72 74 70 70 
32 Ramya 25 60 62 58 68 62 64 58 56 62 56 
33 Shakila 23 72 70 82 74 72 76 72 68 64 76 
34 Poongavanam 28 62 56 58 60 54 50 52 54 56 59 
35 Sargunam 35 72 76 74 78 62 64 68 74 68 72 
36 Asha 25 48 52 56 54 52 68 62 64 60 58 
37 Priya 23 72 68 82 68 63 72 68 72 70 74 
38 Rani 28 72 72 68 64 68 68 64 72 70 68 
39 Magdalin Mary 26 68 74 72 72 68 62 64 66 68 68 
40 Datchayini 26 76 74 80 82 82 84 86 82 78 72 
 
 GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age 
DIASTOLIC BLOOD PRESSURE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
1 Arthi 23 
79 85 89 83 82 75 76 82 88 92 
2 Sathya 22 
87 89 86 87 85 87 85 88 85 84 
3 Devi 26 
94 103 97 97 97 97 98 93 96 99 
4 Abirami 21 
86 89 103 101 96 93 88 93 88 85 
5 Hemapriya 23 
68 72 77 70 74 71 71 76 74 75 
6 Velva 30 
102 100 101 93 88 91 91 87 87 81 
7 Kavitha 29 
89 83 79 100 100 90 84 84 81 83 
8 Jeyanthi 22 
73 99 97 104 95 93 97 95 87 82 
9 Jothi 28 
65 91 82 75 79 85 83 81 78 75 
10 Durga 21 
76 83 85 91 102 89 81 79 86 85 
11 Velvizhi 32 
84 80 89 89 89 86 97 89 93 90 
12 Rukmani 35 
67 79 91 81 82 83 79 74 73 85 
13 Sathya 21 
88 96 100 107 95 91 95 85 82 89 
14 Latha Ramesh  26 
74 93 83 81 83 85 77 77 73 83 
15 Jennifer 21 
75 81 85 90 97 86 84 81 80 79 
16 Revathy 33 
72 92 95 93 94 92 88 82 83 79 
17 Devi 26 
65 76 80 85 79 80 83 81 81 84 
18 Annapoorani 28 
67 69 73 73 71 74 71 73 76 81 
19 Dhanalakshmi 32 
87 88 92 103 91 89 93 90 90 89 
20 Divya 22 
85 83 84 80 79 82 83 78 80 78 
 
 GROUP C – NO TAP BLOCK 
S 
No Name Age 
DIASTOLIC BLOOD PRESSURE 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
21 Gomathi 26 89 91 98 99 102 99 96 91 91 91 
22 Devi 25 97 93 92 89 95 85 81 77 79 84 
23 Girija 25 81 85 93 99 93 91 88 88 85 84 
24 Manimegalai 22 83 88 88 90 82 87 82 79 81 81 
25 Sangeetha 20 87 85 92 95 95 91 86 87 89 83 
26 Sathya 25 79 81 81 84 78 77 78 83 81 82 
27 Eromiya 24 75 75 75 76 78 77 81 81 83 80 
28 Nagammal 23 81 86 88 85 87 85 89 84 82 84 
29 Nithya 25 69 70 69 70 73 69 70 69 67 67 
30 Lakshmi 32 90 94 93 89 95 92 91 92 88 89 
31 Ramya 21 79 80 79 85 90 82 86 85 83 83 
32 Ramya 25 73 77 76 81 77 77 72 71 78 73 
33 Shakila 23 85 81 91 85 88 87 83 81 79 93 
34 Poongavanam 28 74 73 75 77 77 74 73 73 73 77 
35 Sargunam 35 87 85 85 89 78 79 81 87 85 85 
36 Asha 25 65 72 70 68 67 83 75 75 73 72 
37 Priya 23 87 83 91 82 81 88 85 85 82 87 
38 Rani 28 84 87 85 80 80 79 79 84 80 83 
39 Magdalin Mary 26 84 86 83 85 87 84 82 83 84 83 
40 Datchayini 26 87 87 91 95 96 97 99 97 92 87 
 
 GROUP T – TRANSVERSE ABDOMINIS PLANE BLOCK 
S 
No Name Age 
MAP 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
1 Arthi 23 
79 85 89 83 82 75 76 82 88 92 
2 Sathya 22 
87 89 86 87 85 87 85 88 85 84 
3 Devi 26 
94 103 97 97 97 97 98 93 96 99 
4 Abirami 21 
86 89 103 101 96 93 88 93 88 85 
5 Hemapriya 23 
68 72 77 70 74 71 71 76 74 75 
6 Velva 30 
102 100 101 93 88 91 91 87 87 81 
7 Kavitha 29 
89 83 79 100 100 90 84 84 81 83 
8 Jeyanthi 22 
73 99 97 104 95 93 97 95 87 82 
9 Jothi 28 
65 91 82 75 79 85 83 81 78 75 
10 Durga 21 
76 83 85 91 102 89 81 79 86 85 
11 Velvizhi 32 
84 80 89 89 89 86 97 89 93 90 
12 Rukmani 35 
67 79 91 81 82 83 79 74 73 85 
13 Sathya 21 
88 96 100 107 95 91 95 85 82 89 
14 Latha Ramesh  26 
74 93 83 81 83 85 77 77 73 83 
15 Jennifer 21 
75 81 85 90 97 86 84 81 80 79 
16 Revathy 33 
72 92 95 93 94 92 88 82 83 79 
17 Devi 26 
65 76 80 85 79 80 83 81 81 84 
18 Annapoorani 28 
67 69 73 73 71 74 71 73 76 81 
19 Dhanalakshmi 32 
87 88 92 103 91 89 93 90 90 89 
20 Divya 22 
85 83 84 80 79 82 83 78 80 78 
 
 GROUP C – NO TAP BLOCK 
S 
No Name Age 
MAP 
15 min 30 min 2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs 36hrs 48 hrs 
21 Gomathi 26 89 91 98 99 102 99 96 91 91 91 
22 Devi 25 97 93 92 89 95 85 81 77 79 84 
23 Girija 25 81 85 93 99 93 91 88 88 85 84 
24 Manimegalai 22 83 88 88 90 82 87 82 79 81 81 
25 Sangeetha 20 87 85 92 95 95 91 86 87 89 83 
26 Sathya 25 79 81 81 84 78 77 78 83 81 82 
27 Eromiya 24 75 75 75 76 78 77 81 81 83 80 
28 Nagammal 23 81 86 88 85 87 85 89 84 82 84 
29 Nithya 25 69 70 69 70 73 69 70 69 67 67 
30 Lakshmi 32 90 94 93 89 95 92 91 92 88 89 
31 Ramya 21 79 80 79 85 90 82 86 85 83 83 
32 Ramya 25 73 77 76 81 77 77 72 71 78 73 
33 Shakila 23 85 81 91 85 88 87 83 81 79 93 
34 Poongavanam 28 74 73 75 77 77 74 73 73 73 77 
35 Sargunam 35 87 85 85 89 78 79 81 87 85 85 
36 Asha 25 65 72 70 68 67 83 75 75 73 72 
37 Priya 23 87 83 91 82 81 88 85 85 82 87 
38 Rani 28 84 87 85 80 80 79 79 84 80 83 
39 Magdalin Mary 26 84 86 83 85 87 84 82 83 84 83 
40 Datchayini 26 87 87 91 95 96 97 99 97 92 87 
 
